Martinez-Raga J, Casado MA, González Saiz F, Oñate J
Budgetary impact analysis of Buprenorphine/Naloxone (Suboxone®) in opioid maintenance treatment in Spain
14th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Madrid, Spain 5-8 nov 2011
Sánchez-de la Rosa R, Sabater E, Casado MA, Arroyo R
Cost-effectiveness Analysis of Disease Modifiying Drugs (Interferons and Glatiramer Acetate) as first line treatments in Remitting-Relapsing Multiple Sclerosis patients
14th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Madrid, Spain 5-8 nov 2011
Sánchez-de la Rosa R, Sabater E, Casado MA
Budget impact analysis of first-line treatment for relapsing-remitting multiple sclerosis in Spain
14th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Madrid, Spain 5-8 nov 2011
Garcia-Jurado L , Morano R, Torné A, Malvar A, Bayas JM, Pérez-Escolano I, Casado MA
Cost-efectiveness analysis of cervical cancer vaccination strategies in Spain
14th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Madrid, Spain 5-8 nov 2011
Álvarez-Sabín J, Masjuan, J, Yébenes M, Mar J, Oliva J, González-Rojas N, Becerra V, Casado MA, CONOCES Study Investigators
Are hospital costs for stroke underestimated in Spain?
14th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Madrid, Spain 5-8 nov 2011
Fernández-Rivera C, Torre-Cisneros J, Guirado-Perich L, Oyagüez I, Ruiz-Beato E